Extensive and severe CNS demyelination associated with golimumab therapy

被引：10
作者：
Maillart, Elisabeth [1 ]
Papeix, Caroline [1 ]
Mellerio, Charles [2 ,3 ]
Bertrand, Anne [4 ]
Lubetzki, Catherine [1 ]
Louapre, Celine [1 ]
机构：
[1] Hop La Pitie Salpetriere, APHP, Dept Neurol, 47-83 Blvd Hop, F-75013 Paris, France
[2] St Anne Hosp, Dept Neuroradiol, Ctr Psychiat & Neurosci, INSERM,U894, Paris, France
[3] XV XX Hosp, Dept Neuroradiol, Paris, France
[4] Hop La Pitie Salpetriere, APHP, Diagnost & Funct Neuroradiol Dept, Paris, France
来源：
JOURNAL OF NEUROLOGY | 2016年 / 263卷 / 09期
关键词：
ALPHA THERAPY; ARTHRITIS;
D O I：
10.1007/s00415-016-8238-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1869 / 1871
页数：3
相关论文
共 11 条
  • [1] Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy
    Cereda, C. W.
    Zecca, C.
    Mazzucchelli, L.
    Valci, L.
    Staedler, C.
    Bassetti, C. L.
    Gobbi, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (06) : 820 - 823
  • [2] Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review
    Cruz Fernandez-Espartero, Maria
    Perez-Zafrilla, Beatriz
    Naranjo, Antonio
    Esteban, Carmen
    Ortiz, Ana M.
    Gomez-Reino, Juan J.
    Carmona, Loreto
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (03) : 524 - 533
  • [3] Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Kay, Jonathan
    Fleischmann, Roy
    Keystone, Edward
    Hsia, Elizabeth C.
    Hsu, Benjamin
    Mack, Michael
    Goldstein, Neil
    Braun, Juergen
    Kavanaugh, Arthur
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 538 - 546
  • [4] New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review
    Matsumoto, Takumi
    Nakamura, Ichiro
    Miura, Ayumi
    Momoyama, Gen
    Ito, Katsumi
    [J]. CLINICAL RHEUMATOLOGY, 2013, 32 (02) : 271 - 275
  • [5] Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO
  • [6] 2-W
  • [7] Safety of Anti-Tumor Necrosis Factor Therapies in Arthritis Patients
    Nanau, Radu M.
    Neuman, Manuela G.
    [J]. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (03): : 324 - 361
  • [8] Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
    Polman, Chris H.
    Reingold, Stephen C.
    Banwell, Brenda
    Clanet, Michel
    Cohen, Jeffrey A.
    Filippi, Massimo
    Fujihara, Kazuo
    Havrdova, Eva
    Hutchinson, Michael
    Kappos, Ludwig
    Lublin, Fred D.
    Montalban, Xavier
    O'Connor, Paul
    Sandberg-Wollheim, Magnhild
    Thompson, Alan J.
    Waubant, Emmanuelle
    Weinshenker, Brian
    Wolinsky, Jerry S.
    [J]. ANNALS OF NEUROLOGY, 2011, 69 (02) : 292 - 302
  • [9] Autoimmune diseases induced by biological agents A double-edged sword?
    Ramos-Casals, Manuel
    Roberto-Perez-Alvarez
    Diaz-Lagares, Candido
    Cuadrado, Maria-Jose
    Khamashta, Munther A.
    [J]. AUTOIMMUNITY REVIEWS, 2010, 9 (03) : 188 - 193
  • [10] Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey
    Seror, Raphaele
    Richez, Christophe
    Sordet, Christelle
    Rist, Stephanie
    Gossec, Laure
    Direz, Guillaume
    Houvenagel, Eric
    Berthelot, Jean-Marie
    Pagnoux, Christian
    Dernis, Emmanuelle
    Melac-Ducamp, Sylvie
    Bouvard, Beatrice
    Asquier, Caroline
    Martin, Antoine
    Puechal, Xavier
    Mariette, Xavier
    [J]. RHEUMATOLOGY, 2013, 52 (05) : 868 - 874
12